Cover Image
市場調查報告書

高鉀血症:全球臨床實驗趨勢

Hyperkalemia Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 362987
出版日期 內容資訊 英文 59 Pages
訂單完成後即時交付
價格
Back to Top
高鉀血症:全球臨床實驗趨勢 Hyperkalemia Global Clinical Trials Review, H2, 2017
出版日期: 2017年09月27日 內容資訊: 英文 59 Pages
簡介

本報告提供量鉀血症相關臨床研究最新趨勢相關分析,疾病、治療方法概要,及主要國家 (已開發國家/新興國家) 的臨床實驗狀況,各地區、相位的進展,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊彙整,為您概述為以下內容。

目錄

  • 本報告概要
  • 各地區的臨床實驗情形
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區的主要國家的臨床實驗數量
      • 歐洲前五名國家的臨床實驗數量
      • 北美的主要國家的臨床實驗數量
      • 中東、非洲的主要國家的臨床實驗數量
  • 在G7各國的臨床實驗數量:對代謝障礙整體比率
  • 在G7各國的臨床實驗數量:各相位
  • 在G7各國的臨床實驗數量:各進展狀況
  • 在E7各國的臨床實驗數量:對代謝障礙整體比率
  • 在E7各國的臨床實驗數量: 各相位
  • 在E7各國的臨床實驗數量:各進展狀況
  • 各相位的臨床實驗數量
    • 進行中的臨床實驗:各階段
  • 各進展狀況臨床實驗數量
  • 臨床實驗的目標達成情形
  • 一定期間所採用的實驗對象
  • 贊助商的各種類的臨床實驗數量
  • 有潛力的贊助商
    • 參加高鉀血症的治療藥臨床實驗的前幾名企業
  • 有潛力的藥劑
    • 高鉀血症臨床實驗的最新趨勢 (共3件)
  • 臨床實驗簡介:概要
  • 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4614CTIDB

GlobalData's clinical trial report, "Hyperkalemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperkalemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperkalemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Clinical Trials by G7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Hyperkalemia Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Clinical Trial Profile Snapshots 28

Appendix 57

  • Abbreviations 57
  • Definitions 57
  • Research Methodology 58
  • Secondary Research 58
  • About GlobalData 59
  • Contact Us 59
  • Source 59

List of Tables

List of Tables

  • Hyperkalemia Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Hyperkalemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Hyperkalemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Hyperkalemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Hyperkalemia Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Hyperkalemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 13
  • Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 16
  • Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Hyperkalemia Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
  • Hyperkalemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Hyperkalemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Hyperkalemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Hyperkalemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
  • Hyperkalemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Hyperkalemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Hyperkalemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures

List of Figures

  • Hyperkalemia Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Hyperkalemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Hyperkalemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Hyperkalemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Hyperkalemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Hyperkalemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
  • Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 13
  • Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Hyperkalemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 16
  • Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Hyperkalemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Hyperkalemia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Hyperkalemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
  • Hyperkalemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Hyperkalemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Hyperkalemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Hyperkalemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
  • Hyperkalemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Hyperkalemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Hyperkalemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
  • GlobalData Methodology 58
Back to Top